Skip to main content

ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Neonatology

Volume 13 - 2025 | doi: 10.3389/fped.2025.1567091

Longitudinal Transcriptomic Analysis of the Hyperoxia-exposed Preterm Rabbit as a Model of BPD

Provisionally accepted
Carlotta Boggi Carlotta Boggi 1Nicola Casiraghi Nicola Casiraghi 2Xabier Murgia Xabier Murgia 3Silvia Parolo Silvia Parolo 2Enrica Scalera Enrica Scalera 1Giorgio Aquila Giorgio Aquila 1Chiara Catozzi Chiara Catozzi 1Salomone Fabrizio Salomone Fabrizio 1Francesca Stretti Francesca Stretti 1,4Ilaria Minato Ilaria Minato 5Francesca Ravanetti Francesca Ravanetti 4Luisa Ragionieri Luisa Ragionieri 4Roberta Ciccimarra Roberta Ciccimarra 4Matteo Zoboli Matteo Zoboli 4Gino Villetti Gino Villetti 1BARBARA MONTANINI BARBARA MONTANINI 5*Francesca Ricci Francesca Ricci 6Matteo Storti Matteo Storti 6*
  • 1 Department of Experimental Pharmacology and Translational Science. R&D, Chiesi Farmaceutici (Italy), Parma, Emilia-Romagna, Italy
  • 2 Fondazione The Microsoft Research, COSBI - Center for Computational and Systems Biology, University of Trento, Rovereto, Italy
  • 3 Scientific Consultancy, Bilbao, Basque Country, Spain
  • 4 Department of Veterinary Science, University of Parma, Parma, Emilia-Romagna, Italy
  • 5 Laboratory of Biochemistry and Molecular Biology, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Emilia-Romagna, Italy
  • 6 Department of Experimental Pharmacology and Translational Science. R&D,, Chiesi Farmaceutici (Italy), Parma, Emilia-Romagna, Italy

The final, formatted version of the article will be published soon.

    Bronchopulmonary dysplasia (BPD) is a multifactorial chronic lung disease of premature neonates. BPD development depends on prenatal and postnatal factors that induce inflammation, altering alveolar growth and pulmonary vascular development. Animal models are essential to investigate the precise molecular pathways leading to BPD. The preterm rabbit combines many advantages of small (e.g., rodents) and large BPD models (e.g., preterm lambs and baboons). Preterm rabbits display mild-to-moderate respiratory distress at delivery, which, along with continuous exposure to hyperoxia (95% O2), leads to functional and morphological lung changes resembling a BPD-like phenotype. Nevertheless, the molecular pathways leading to the BPD-like phenotype remain poorly understood. Here, we aimed to characterize the longitudinal gene expression in the lungs of preterm rabbits exposed to 95% O2, on postnatal days 3, 5, and 7. Histological analyses confirmed extensive lung injury and reduced lung development after 7 days of hyperoxia. Longitudinal transcriptomic analysis revealed different expression patterns for several genes and pathways. Over time, extracellular matrix organization and angiogenesis were increasingly downregulated. Apoptosis, RNA processing, and inflammation showed the opposite trend. We also investigated the expression of representative genes of these pathways, whose signatures could aid in developing pharmacological treatments in the context of BPD.

    Keywords: Bronchopulmonary Dysplasia, Preterm Rabbits, Transcriptomics, Hyperoxia, Inflammation

    Received: 26 Jan 2025; Accepted: 07 Apr 2025.

    Copyright: © 2025 Boggi, Casiraghi, Murgia, Parolo, Scalera, Aquila, Catozzi, Fabrizio, Stretti, Minato, Ravanetti, Ragionieri, Ciccimarra, Zoboli, Villetti, MONTANINI, Ricci and Storti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    BARBARA MONTANINI, Laboratory of Biochemistry and Molecular Biology, Department of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, 43121, Emilia-Romagna, Italy
    Matteo Storti, Department of Experimental Pharmacology and Translational Science. R&D,, Chiesi Farmaceutici (Italy), Parma, Emilia-Romagna, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more